Risk factors for recurrence of borderline ovarian tumours: A tertiary centre experience

被引：4

作者：

Demirkiran, Fuat ^{[1
]}

Sal, Veysel ^{[1
]}

Bese, Tugan ^{[1
]}

Tokgozoglu, Nedim ^{[1
]}

Erenel, Hakan ^{[2
]}

Sofiyeva, Nigar ^{[1
]}

Kahramanoglu, Ilker ^{[1
]}

Arvas, Macit ^{[1
]}

机构：

[1] Istanbul Univ, Cerrahpasa Fac Med, Div Gynecol Oncol, Dept Obstet & Gynecol, Istanbul, Turkey

[2] Sisli Hamidiye Etfal Training & Res Hosp, Dept Obstet & Gynecol, Istanbul, Turkey

来源：

JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2016年 / 36卷 / 08期

关键词：

Borderline; ovarian; prognostic factors; recurrence; surgery; SURVIVAL; PATTERNS; IMPLANTS; OUTCOMES; WOMEN;

D O I：

10.1080/01443615.2016.1188276

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The aim of this study was to evaluate the risk factors for recurrence of borderline ovarian tumours. This study investigated 127 women who were finally diagnosed with borderline epithelial ovarian tumours. Most of them were diagnosed in stage I (83.4%). With a median follow-up of 81.8 months (range: 14-205), the median time to recurrence was 22.4 months (range: 3-74). Five-year recurrence-free survival (RFS) and overall survival (OS) rates were 85.8% and 97.6%, respectively. In multivariate analysis, invasive implants and fertility-sparing surgery were found to be independent prognostic factors for 5-year RFS. Overall, 20 patients (15.7%) experienced relapse within the observation period. Although there is no consensus about high-risk category of borderline ovarian tumours, invasive implants and conservative surgery were closely related to the recurrence. Patients presenting these risk factors should undergo closer follow-up.

引用

页码：1036 / 1040

页数：5

共 50 条

[41] Risk of Recurrence and Management of Borderline Ovarian Tumors.
Black, Jonathan D.
Rutherford, Thomas J.
Ratner, Elena
Yoo, Naomi
Azodi, Masoud
Buza, Natalia
Tavassoli, Fattaneh
Schwartz, Peter E.
REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 312A - 312A
[42] TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumours
Losi, Lorena
Botticelli, Laura
Garagnani, Lorella
Fabbiani, Luca
Panini, Rossana
Gallo, Graziana
Sabbatini, Roberto
Maiorana, Antonino
Benhattar, Jean
PATHOLOGY, 2021, 53 (02) : 187 - 192
[43] Reproductive outcomes in women with Borderline Ovarian Tumours. Does fertility treatment increase the risk of disease recurrence?
Kasaven, L.
Jones, B.
Saravelos, S.
Ben Nagi, J.
El-Bahrawy, M.
Sousi, S.
Ghaem-Maghami, S.
Srdjan, S.
Yazbek, J.
Lavery, S.
HUMAN REPRODUCTION, 2022, 37 : I113 - I113
[44] Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis
Buis, C. C. M.
van Leeuwen, F. E.
Mooij, T. M.
Burger, C. W.
HUMAN REPRODUCTION, 2013, 28 (12) : 3358 - 3369
[45] In vitro fertilization is associated with an increased risk of borderline ovarian tumours
Stewart, Louise M.
Holman, C. D'Arcy J.
Finn, Judith C.
Preen, David B.
Hart, Roger
GYNECOLOGIC ONCOLOGY, 2013, 129 (02) : 372 - 376
[46] Management of borderline ovarian tumours
Bagade, Pallavi
Edmondson, Richard
Nayar, Anitha
OBSTETRICIAN & GYNAECOLOGIST, 2012, 14 (02): : 115 - 120
[47] Management of borderline ovarian tumours
Gershenson, David M.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 41 : 49 - 59
[48] Pathology of borderline ovarian tumours
Manek, S
Wells, M
CLINICAL ONCOLOGY, 1999, 11 (02) : 73 - 77
[49] Borderline Ovarian Tumours : An Update
Priya, C.
Kumar, Sunesh
Kumar, Lalit
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (02) : 19 - 27
[50] Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN group
Sangnier, E.
Ouldamer, L.
Bendifallah, S.
Huchon, C.
Collinet, P.
Bricou, A.
Mimoun, C.
Lecointre, L.
Graesslin, O.
Raimond, E.
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2021, 50 (04)

← 1 2 3 4 5 →